AXQ Capital’s Organogenesis Holdings ORGO Stock Holding History

AXQ Capital’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,562	Closed	-$189K	–	1194
2025 Q4	$189K	Buy	+36,562	New	+$177K	0.04%	581

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AXQ Capital's ORGO Position: Q1 2026 in Review

AXQ Capital sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 36,562 shares — an estimated $189K sold.

AXQ Capital first reported a position in ORGO in Q4 2025 and held it in 1 quarter. The position peaked at $189K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

AXQ Capital reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 36,562 Organogenesis Holdings shares in Q1 2026, an estimated $189K.
AXQ Capital first reported a position in Organogenesis Holdings in Q4 2025 and held it in 1 quarter.
AXQ Capital's Organogenesis Holdings position peaked at $189K in Q4 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.